Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies

Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series

(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · see citing works

Estimating the mean and variance from the median, range, and the size of a sample

Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062 · see citing works

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · see citing works

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works

Alternative activation of macrophages: mechanism and functions

Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197 · see citing works

Bipolar Disorder

Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515 · see citing works

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819 · see citing works

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · see citing works

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

Potvin, S., Stip, É., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, É. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 989 · see citing works

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794 · see citing works

Blood Pressure and Inflammation in Apparently Healthy Men

Chae, C. U., Lee, R. T., Rifai, N., & Ridker, P. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.399 · Cited by 716 · see citing works

The soluble interleukin 6 receptor: mechanisms of production and implications in disease

Jones, S. A., Horiuchi, S., Topley, N., Yamamoto, N., & Fuller, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 684 · see citing works

Effect of alcohol consumption on systemic markers of inflammation

Imhof, A., Froehlich, M., Brenner, H., Boeing, H., Pepys, M. B., & Koenig, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04170-2 · Cited by 559 · see citing works

IL-10–producing and naturally occurring CD4+ Tregs: limiting collateral damage

O’Garra, A., Vieira, P. L., Vieira, P., & Goldfeld, A. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23215 · Cited by 530 · see citing works

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder

Goldstein, B. I., Kemp, D. E., Soczynska, J. K., & McIntyre, R. S. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04505 · Cited by 510 · see citing works

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder

Kauer‐Sant’Anna, M., Kapczinski, F. P., Andreazza, A. C., Bond, D. J., Lam, R. W. M., Young, L. T., & Yatham, L. N. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009310 · Cited by 434 · see citing works

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423 · see citing works

IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity

Oswald, I. P., Gazzinelli, R. T., Sher, A., & James, S. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3578 · Cited by 412 · see citing works

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

Maes, M. H. J., Bosmans, E., Calabrese, J. R., Smith, R. S., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385 · see citing works

Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder

Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375 · see citing works

Mental Disorders and Asthma in the Community

Goodwin, R. D., Jacobi, F., & Thefeld, W. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1125 · Cited by 347 · see citing works

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 344 · see citing works

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

Maes, M. H. J., Delange, J., Ranjan, R., Meltzer, H. Y., Desnyder, R., Cooremans, W., & Scharpé, S. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)02915-0 · Cited by 341 · see citing works

A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes

Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336 · see citing works

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis

Haack, M., Hinze‐Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329 · see citing works

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study

Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298 · see citing works

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285 · see citing works

Regulatory T Cells

Beissert, S., Schwarz, A., & Schwarz, T. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700004 · Cited by 256 · see citing works

Cytokines in bipolar disorder: A systematic review and meta-analysis

Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · see citing works

The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex

Jones, S. A., & Rose‐John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 256 · see citing works

Immune variations in bipolar disorder: phasic differences

Ortiz‐Domínguez, A., Hernández, M. E., Berlanga, C., Gutiérrez‐Mora, D., Moreno, J., Heinze, G., & Pavón, L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00493.x · Cited by 255 · see citing works

Α Review on the Acute Phase Response in Major Depression

Maes, M. (1993) · Reviews in the Neurosciences · doi:10.1515/revneuro.1993.4.4.407 · Cited by 239 · see citing works

Peripheral biomarkers and illness activity in bipolar disorder

Kapczinski, F. P., Dal‐Pizzol, F., Teixeira, A. L., Magalhães, P. V. D. S., Kauer‐Sant’Anna, M., Klamt, F., Moreira, J. C. F., Pasquali, M. A. D. B., Fries, G. R., Quevedo, J., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.05.015 · Cited by 236 · see citing works

The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.

Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224 · see citing works

Cigarette Smoking Influences Cytokine Production and Antioxidant Defences

Tappia, P. S., Troughton, K. L., Langley‐Evans, S. C., & Grimble, R. F. (1995) · Clinical Science · doi:10.1042/cs0880485 · Cited by 222 · see citing works

Localization of estrogen receptor ?-immunoreactivity in astrocytes of the adult rat brain

Azcoitia, Í., Sierra, A., & García‐Segura, L. M. (1999) · Glia · doi:10.1002/(sici)1098-1136(199905)26:3 · Cited by 222 · see citing works

Medical Comorbidity in Bipolar Disorder: Implications for Functional Outcomes and Health Service Utilization

McIntyre, R. S., Konarski, J. Z., Soczynska, J. K., Wilkins, K., Panjwani, G., Bouffard, B., Bottas, A., & Kennedy, S. H. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.8.1140 · Cited by 198 · see citing works

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Kunz, M., Ceresér, K. M. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. S. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000300010 · Cited by 189 · see citing works

The activation of monocyte and T cell networks in patients with bipolar disorder

Drexhage, R. C., Hoogenboezem, T., Versnel, M. A., Berghout, A., Nolen, W. A., & Drexhage, H. A. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.013 · Cited by 172 · see citing works

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

Kapczinski, F. P., Dias, V. V., Kauer‐Sant’Anna, M., Brietzke, E. M., Vázquez, G. H., Vieta, E., & Berk, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.027 · Cited by 167 · see citing works

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.

Hope, S., Dieset, I., Agartz, I., Steen, N. E., Ueland, T., Melle, I., Aukrust, P., & Andreassen, O. A. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.08.003 · Cited by 164 · cited 4× · see citing works

Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus

Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S. L., Alsuwaidan, M. T., Yim, C. Y., & McIntyre, R. S. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 162 · see citing works

Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder

Dickerson, F., Stallings, C. R., Origoni, A. E., Boronow, J. J., & Yolken, R. H. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.018 · Cited by 157 · see citing works

Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial

Sepanjnia, K., Modabbernia, A., Ashrafi, M., Modabbernia, M.-J., & Akhondzadeh, S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.58 · Cited by 153 · see citing works

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

Hope, S., Melle, I. S., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 152 · see citing works

High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder

Breunis, M. N., Kupka, R., Nolen, W. A., Suppes, T. M., Denicoff, K. D., Leverich, G. S., Post, R. M., & Drexhage, H. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01452-x · Cited by 149 · see citing works

An imbalance in the production of IL‐1β and IL‐6 by monocytes of bipolar patients: restoration by lithium treatment

Knijff, E. M., Breunis, M. N., Kupka, R., de Wit, H. J., Ruwhof, C., Akkerhuis, G. W., Nolen, W. A., & Drexhage, H. A. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00444.x · Cited by 146 · see citing works

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

Hope, S., Ueland, T., Steen, N. E., Dieset, I., Lorentzen, S., Berg, A. O., Agartz, I., Aukrust, P., & Andreassen, O. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.023 · Cited by 131 · see citing works

Cytokine production in bipolar affective disorder patients under lithium treatment

Boufidou, F., Nikolaou, C., Alevizos, B., Liappas, I. A., & Christodoulou, G. N. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.01.007 · Cited by 130 · see citing works

Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder

do Prado, C. H., Rizzo, L. B., Wieck, A., Lopes, R. P., Teixeira, A. L., Grassi‐Oliveira, R., & Bauer, M. E. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.08.005 · Cited by 127 · see citing works

Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder

Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 127 · see citing works

Role of oxidative stress in the pathophysiology of bipolar disorder

Steckert, A. V., Valvassori, S. S., Moretti, M., Dal‐Pizzol, F., & Quevedo, J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0195-2 · Cited by 125 · see citing works

Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers

Barbosa, I. G., Rocha, N. P., Huguet, R. B., Ferreira, R. A., Salgado, J. V., de Carvalho, L. A., Pariante, C. M., & Teixeira, A. L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.034 · Cited by 121 · see citing works

Immunologic variables in acute mania of bipolar disorder

Liu, H., Yang, Y., Chou, Y.-M., Chen, K.-P., Shen, W. W., & Leu, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.006 · Cited by 118 · see citing works

A Cohort Study of the Prevalence and Impact of Comorbid Medical Conditions in Pediatric Bipolar Disorder

Jerrell, J. M., McIntyre, R. S., & Tripathi, A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05585ora · Cited by 111 · see citing works

Activation of indices of cell-mediated immunity in bipolar mania

Tsai, S., Chen, K.-P., Yang, Y., Chen, C., Lee, J.-C., Singh, V. K., & Leu, S.-J. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00159-0 · Cited by 111 · see citing works

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.

Barbosa, I. G., Huguet, R. B., Mendonça, V. A., Sousa, L. P., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0116-z · Cited by 108 · see citing works

Tryptophan breakdown pathway in bipolar mania

Myint, A.-M., Kim, Y., Verkerk, R. M., Park, S. H., Scharpé, S., Steinbusch, H. W. M., & Leonard, B. E. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.12.008 · Cited by 106 · see citing works

Serum concentrations of tumour necrosis factor‐alpha (TNF‐α) and soluble TNF‐α receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function

Díez, J. J., Hernánz, Á., Medina, S., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01629.x · Cited by 106 · see citing works

Activation of gp 130 by IL‐6/soluble IL‐6 receptor induces neuronal differentiation

März, P., Herget, T., Lang, E., Otter, U., & Rose‐John, S. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01705.x · Cited by 103 · see citing works

Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder

Tsai, S., Chung, K., Wu, J.-Y., Kuo, C., Lee, H., & Huang, S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.022 · Cited by 102 · see citing works

Cytokine levels in euthymic bipolar patients

Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.027 · Cited by 102 · see citing works

Towards a multifactorial approach for prediction of bipolar disorder in at risk populations

Brietzke, E. M., Mansur, R. B., Soczynska, J. K., Kapczinski, F. P., Bressan, R. A., & McIntyre, R. S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.016 · Cited by 101 · see citing works

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.

Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, S.-W., Leonard, B. E., & Steinbusch, H. W. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.08.005 · Cited by 100 · see citing works

A high prevalence of organ-specific autoimmunity in patients with bipolar disorder

Padmos, R. C., Bekris, L. M., Knijff, E. M., Tiemeier, H. W., Kupka, R., Cohen, D., Nolen, W. A., Lernmark, Å., & Drexhage, H. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.003 · Cited by 100 · see citing works

Immune parameters in rapid cycling bipolar patients before and after lithium treatment

Rapaport, M. H. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00007-2 · Cited by 99 · see citing works

Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders

Goldstein, B. I., Collinger, K. A., Lotrich, F. E., Marsland, A. L., Gill, M., Axelson, D., & Birmaher, B. B. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0009 · Cited by 97 · see citing works

From neuroprogression to neuroprotection: implications for clinical care.

Berk, M., Conus, P., Kapczinski, F. P., Andreazza, A. C., Yücel, M., Wood, S. J., Pantelis, C., Malhi, G. S., Dodd, S., Bechdolf, A., et al. (2010) · PubMed · Cited by 96 · see citing works

Reduced antioxidant defense systems in schizophrenia and bipolar I disorder

Raffa, M., Barhoumi, S., Atig, F., Fendri, C., Kerkeni, A., & Mechri, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.013 · Cited by 95 · see citing works

Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania

Tsai, S., Yang, Y.-Y., Kuo, C.-J., Chen, C., & Leu, S.-J. C. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00252-4 · Cited by 95 · see citing works

The effector T helper cell triade.

Fietta, P., & Delsante, G. (2009) · PubMed · Cited by 92 · see citing works

Serotonergic and Noradrenergic Markers of Post-Traumatic Stress Disorder with and without Major Depression

Maes, M. H. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00058-x · Cited by 86 · see citing works

Increased levels of adipokines in bipolar disorder

Barbosa, I. G., Rocha, N. P., de Miranda, A. S., Magalhães, P. V. D. S., Huguet, R. B., de Souza, L. P., Kapczinski, F. P., & Teixeira, A. L. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.010 · Cited by 83 · see citing works

Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder

Papiol, S., Rosa, A., Gutiérrez, B., Martín, B., Salgado, P., Catalán, R., Arias, B., & Fañanás, L. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.012914 · Cited by 80 · see citing works

Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder

Hung, Y., Hsieh, C., Chen, Y., Pei, D., Kuo, S., Shen, D., Sheu, W. H., & Chen, Y. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02963.x · Cited by 79 · see citing works

Cytokines and Neurotrophins Interact in Normal and Diseased States

Otten, U., März, P., Heese, K., Hock, C., KUNZ, D., & Rose‐John, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05398.x · Cited by 75 · see citing works

A Simple Method for Obtaining Original Data from Published Graphs and Plots

Sistrom, C. L., & Mergo, P. J. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.5.1741241 · Cited by 63 · see citing works

Immune parameters in euthymic bipolar patients and normal volunteers

Rapaport, M. H. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90012-4 · Cited by 62 · see citing works

Impaired nerve growth factor homeostasis in patients with bipolar disorder

Barbosa, I. G., Huguet, R. B., Neves, F. S., Reis, H. J., Bauer, M. E., Janka, Z., Palotás, A., & Teixeira, A. L. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.518629 · Cited by 61 · see citing works

Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin‐1 beta gene (2q13)

Papiol, S., Molina, V., Desco, M., Rosa, A., Reig, S., Sanz, J., Palomo, T., & Fañanás, L. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00421.x · Cited by 59 · see citing works

Cytokines in Bipolar Disorder: Recent Findings, Deleterious Effects But Promise for Future Therapeutics

Brietzke, E., Stabellini, R., Grassi-Oliveira, R., & Lafer, B. (2011) · CNS Spectrums · doi:10.1017/s1092852912000338 · Cited by 57 · see citing works

Evidence for an association between tumor necrosis factor-alpha levels and lithium response

Gülöksüz, S., Altınbaş, K., Çetin, E. A., Kenis, G., Gazioğlu, S. B., Deniz, G., Oral, E., & van Os, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.044 · Cited by 55 · see citing works

Occupational status and social adjustment six months after hospitalization early in the course of bipolar disorder: a prospective study

Dickerson, F., Origoni, A. E., Stallings, C. R., Khushalani, S., Dickinson, D., & Medoff, D. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00784.x · Cited by 53 · see citing works

Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission

Su, K., Leu, S.-J. C., Yang, Y., Shen, W. W., Chou, Y.-M., & Tsai, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00369-x · Cited by 53 · see citing works

A relative resistance of T cells to dexamethasone in bipolar disorder

Knijff, E. M., Breunis, M. N., Geest, M. C. V., Kupka, R., Ruwhof, C., de Wit, H. J., Nolen, W. A., & Drexhage, H. A. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00359.x · Cited by 52 · see citing works

Changes in Allergy Symptoms and Depression Scores Are Positively Correlated In Patients With Recurrent Mood Disorders Exposed to Seasonal Peaks in Aeroallergens

Postolache, T. T., Lapidus, M., Sander, E. R., LANGENBERG, P. W., Hamilton, R. G., Soriano, J. J., McDonald, J. S., Furst, N., Bai, J., Scrandis, D. A., et al. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.286 · Cited by 51 · see citing works

Brain-Derived Neurotrophic Factor, Adiponectin, and Proinflammatory Markers in Various Subtypes of Depression in Young Men

Su, S., Sun, M.-T., Wen, M.-J., Lin, C.-J., Chen, Y.-C., & Hung, Y. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.3.a · Cited by 50 · see citing works

A random effects variance shift model for detecting and accommodating outliers in meta-analysis

Gumedze, F. N., & Jackson, D. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-19 · Cited by 48 · see citing works

Selected Cytokine Profiles during Remission in Bipolar Patients

Remlinger-Molenda, A., Wójciak, P., Michalak, M., Karczewski, J., & RYBAKOWSKI, J. K. (2012) · Neuropsychobiology · doi:10.1159/000339949 · Cited by 46 · see citing works

Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein

Dieset, I., Hope, S., Ueland, T., Bjella, T. D., Agartz, I., Melle, I. S., Aukrust, P., Røssberg, J. I., & Andreassen, O. A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.040 · Cited by 43 · see citing works

Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder

Kim, S. J., Lee, H. J., Koo, H. G., Kim, J. W., Song, J. Y., Kim, M. K., Shin, D. H., Jin, S. Y., Hong, M. S., Park, H. J., et al. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200409000-00009 · Cited by 40 · see citing works

Therapeutic potential of interleukin-6 antagonism in bipolar disorder

Brietzke, E. M., Scheinberg, M. A., & Lafer, B. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.021 · Cited by 38 · see citing works

[Activity of selected cytokines in bipolar patients during manic and depressive episodes].

Remlinger-Molenda, A., Wójciak, P., Michalak, M., & RYBAKOWSKI, J. K. (2012) · PubMed · Cited by 30 · see citing works

Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms

Cetin, T., Gülöksüz, S., Çetin, E. A., Gazioğlu, S. B., Deniz, G., Oral, E., & van Os, J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-158 · Cited by 30 · see citing works

Evidence that the immunopathogenic mechanism of lithium‐induced psoriasis differs from that of regular psoriasis

Knijff, E. M., Kupka, R., Ruwhof, C., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00214.x · Cited by 18 · see citing works

Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission

Tsai, S., Lee, H., Chen, C., & Lee, C.-H. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00103-6 · Cited by 17 · see citing works

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

Brietzke, E. M., & Teixeira, A. L. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00822.x · Cited by 14 · see citing works

Immediate early inflammatory gene responses of human umbilical vein endothelial cells to hemorrhagic venom

Albrecht, E. A., Dhanasekaran, S. M., & Tomlins, S. A. (2010) · Inflammation Research · doi:10.1007/s00011-010-0286-1 · Cited by 9 · see citing works

P.2.e.024 Cytokine profiles in bipolar affective disorder during acute episodes and in remission

Remlinger-Molenda, A., Wójciak, P., Kostrzewa, A., Karczewski, J., Wiktorowicz, K., & RYBAKOWSKI, J. K. (2010) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(10)70597-6 · Cited by 4 · see citing works

P.2.f.003 No state-dependent alternation of immunological parameters, insulin, and leptin during bipolar depression

Tsai, S., Chung, K., & Huang, S. H. (2010) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(10)70603-9 · Cited by 3 · see citing works

P.2.e.024 The effect of mania on cytokine status in bipolar illness

Remlinger-Molenda, A., Wójciak, P., Karczewski, J., Kostrzewa, A., Wiktorowicz, K., & RYBAKOWSKI, J. K. (2009) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(09)70723-0 · Cited by 2 · see citing works

Serum levels of II6, II10 and TNF-alpha in patients with bipolar disorder in euthymia and with schizophrenia: Differences in pro and anti-inflammatory balance

Kunz, M., Ceresér, K., Fries, G., Teixeira, A. A. D. S., Fernandes, B. S., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. (2010) · Figshare · Cited by 2 · see citing works

Peripheral biomarkers in bipolar disorder: a population-based study in young adults

da Silva, P. V. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000100020 · Cited by 1 · see citing works

P.1.007 Th1, Th2 and Th3 cytokine alterations in bipolar disorder: Effects of mood stabilizers

Kim, Y. K., Myint, A.-M., Han, C. S., et al. (2004) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(04)80096-8 · Cited by 1 · see citing works

Erratum to “Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission”

Su, K., Leu, S.-J. C., Yang, Y., et al. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00364-6 · Cited by 1 · see citing works

Effects of psychotropic agents on plasma levels of soluble interleukin-2 and interleukin-6 receptors in bipolar mania

Lee, H. C., Tsai, S., Leu, S., et al. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80157-1 · Cited by 1 · see citing works

Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder

Brietzke, E. M., Stertz, L., Fernandes, B. S., Kauer‐Sant’Anna, M., Mascarenhas, M. Á., Vargas, A., Chies, J. A. B., & Kapczinski, F. P. (2010) · Figshare · Cited by 1 · see citing works

P.5.019 Plasma levels of tumor necrosis factor-alpha (TNFα) in first-episode bipolar disorder and schizophrenia patients

(2005) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(05)81184-8 · Cited by 1 · see citing works

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · see citing works

So depression is an inflammatory disease, but where does the inflammation come from?

Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., Allen, N. B., Stuart, A. L., Hayley, A. C., Byrne, M. L., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-200 · Cited by 1,423 · see citing works

Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression

Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., & Kauer-Sant'Anna, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00309-0 · Cited by 743 · see citing works

Inflammation in psychiatric disorders: what comes first?

Bauer, M. E., & Teixeira, A. L. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13712 · Cited by 500 · see citing works

Childhood maltreatment and inflammatory markers: a systematic review.

Coelho, R., Viola, T. W., Walss‐Bass, C., Brietzke, E., & Grassi‐Oliveira, R. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12217 · Cited by 426 · see citing works

Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses

Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428 · see citing works

Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis

Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · see citing works

Psychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma?

Danese, A., & J Lewis, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.198 · Cited by 393 · see citing works

Cytokine Research in Depression: Principles, Challenges, and Open Questions

Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313 · see citing works

The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder

Maes, M., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1016-x · Cited by 306 · see citing works

Hidden wounds? inflammatory links between childhood trauma and psychopathology

Danese, A., & Baldwin, J. R. (2017) · Annual Review of Psychology · doi:10.1146/annurev-psych-010416-044208 · Cited by 286 · see citing works

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications

Rosenblat, J., & McIntyre, R. (2017) · Brain Sciences · doi:10.3390/brainsci7110144 · Cited by 258 · see citing works

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30370-4 · Cited by 247 · see citing works

Genetic correlations among psychiatric and immune‐related phenotypes based on genome‐wide association data

Tylee, D. S., Sun, J., Hess, J. L., Tahir, M. A., Sharma, E., Malik, R., Worrall, B. B., Levine, A. J., Martinson, J. J., Nejentsev, S., et al. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32652 · Cited by 219 · see citing works

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works

Association of trauma exposure with proinflammatory activity: a transdiagnostic meta-analysis

Tursich, M., Neufeld, R. W. J., Frewen, P. A., Harricharan, S., Kibler, J. L., Rhind, S. G., & Lanius, R. A. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.56 · Cited by 204 · see citing works

Anti-inflammatory agents in the treatment of bipolar depression: A systematic review and meta-analysis

Rosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199 · see citing works

Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health

Raony, Í., de Figueiredo, C. S., Pandolfo, P., Giestal-de-Araujo, E., Oliveira-Silva Bomfim, P., & Savino, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01170 · Cited by 185 · see citing works

Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers

Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187 · see citing works

The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research

Rizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183 · see citing works

Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications

Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172 · see citing works

Neuropathology of mood disorders: Do we see the stigmata of inflammation?

Mechawar, N., & Savitz, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.212 · Cited by 165 · see citing works

Cytokines as biomarkers in depressive disorder: current standing and prospects

Lichtblau, N., Schmidt, F. M., Schumann, R., Kirkby, K. C., & Himmerich, H. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.813442 · Cited by 155 · see citing works

Neuroinflammation in suicide: Toward a comprehensive model

Courtet, P., Giner, L., Seneque, M., Guillaume, S., Olie, E., & Ducasse, D. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1054879 · Cited by 146 · see citing works

Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors

Baumeister, D., Russell, A., Pariante, C. M., & Mondelli, V. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0887-z · Cited by 142 · see citing works

Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis

Horn, S. R., Long, M. M., Nelson, B. W., Allen, N. B., Fisher, P. A., & Byrne, M. L. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.016 · Cited by 129 · see citing works

Mapping inflammation onto mood: inflammatory mediators of anhedonia

Swardfager, W., Rosenblat, J. D., Benlamri, M., & McIntyre, R. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.017 · Cited by 125 · see citing works

A meta-analysis of cytokines in suicidal behavior

Ducasse, D., Olié, E., Guillaume, S., Artéro, S., & Courtet, P. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.02.004 · Cited by 119 · see citing works

On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review

Pinto, J. V., Moulin, T. C., & Amaral, O. B. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.001 · Cited by 103 · see citing works

Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts

Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.024 · Cited by 104 · see citing works

Monocyte and Lymphocyte Activation in Bipolar Disorder: A New Piece in the Puzzle of Immune Dysfunction in Mood Disorders

Barbosa, I. G., Rocha, N. P., Assis, F., Vieira, E. L. M., Soares, J. C., Bauer, M. E., & Teixeira (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu021 · Cited by 101 · see citing works

Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia

Brambilla, P., Bellani, M., Isola, M., Bergami, A., Marinelli, V, Dusi, N., Rambaldelli, G., Tansella, M., Maria Finardi, A., Martino, G., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.46 · Cited by 86 · see citing works

Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder

Pfaffenseller, B., Fries, G. R., Wollenhaupt-Aguiar, B., Colpo, G. D., Stertz, L., Panizzutti, B., Magalhães, P. V., & Kapczinski, F. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811981 · Cited by 68 · see citing works

Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder.

Siwek, M., Sowa-Kućma, M., Styczeń, K., Misztak, P., Nowak, R. J., Szewczyk, B., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0124-8 · Cited by 65 · see citing works

Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium

Sakrajda, K., & Szczepankiewicz, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041532 · Cited by 65 · see citing works

Bias in emerging biomarkers for bipolar disorder

Carvalho, A. F., Köhler, C. A., Fernandes, B. S., Quevedo, J., Miskowiak, K. W., Brunoni, A. R., Machado-Vieira, R., Maes, M., Vieta, E., & Berk, M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000957 · Cited by 63 · see citing works

Markers of inflammation in schizophrenia: association vs. causation

Manu, P., Correll, C. U., Wampers, M., Mitchell, A. J., Probst, M., Vancampfort, D., & De Hert, M. (2014) · World Psychiatry · doi:10.1002/wps.20117 · Cited by 59 · see citing works

Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: moderation by childhood trauma severity.

Quidé, Y., Bortolasci, C. C., Spolding, B., Kidnapillai, S., Watkeys, O. J., Cohen-Woods, S., Carr, V. J., Berk, M., Walder, K., & Green, M. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110013 · Cited by 44 · see citing works

Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder

Drago, A., Crisafulli, C., Calabrò, M., & Serretti, A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.032 · Cited by 47 · see citing works

Overlapping evidence of innate immune dysfunction in psychotic and affective disorders

Hughes, H. K., & Ashwood, P. (2020) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2020.100038 · Cited by 39 · see citing works

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

Data-Franco, J., Singh, A., Popovic, D., Ashton, M., Berk, M., Vieta, E., Figueira, M. L., & Dean, O. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.004 · Cited by 38 · see citing works

Inflammatory bowel disease and bipolar disorder: A population-based cross-sectional study

Kao, L.-T., Lin, H.-C., & Lee, H.-C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.014 · Cited by 36 · see citing works

Neutrophil/high-density lipoprotein cholesterol (HDL), monocyte/HDL and platelet/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors

Korkmaz, Ş. A., & Kızgın, S. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2260302 · Cited by 33 · see citing works

Elevated lipids are associated with reduced regional brain structure in youth with bipolar disorder

Kennedy, K. G., Islam, A. H., Grigorian, A., Fiksenbaum, L., Mitchell, R. H. B., McCrindle, B. W., MacIntosh, B. J., & Goldstein, B. I. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13278 · Cited by 33 · see citing works

Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation

Howerton, A. R., Roland, A. V., & Bale, T. L. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0118-14.2014 · Cited by 33 · see citing works

Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry

Bortolasci, C. C., Spolding, B., Callaly, E., Martin, S., Panizzutti, B., Kidnapillai, S., Connor, T., Hasebe, K., Mohebbi, M., Dean, O. M., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy014 · Cited by 25 · see citing works

Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes

Torsvik, A., Brattbakk, H.-R., Trentani, A., Holdhus, R., Stansberg, C., Bartz-Johannessen, C. A., Hughes, T., Steen, N. E., Melle, I., Djurovic, S., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02442-1 · Cited by 21 · see citing works

Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder

Wang, T.-Y., Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Wang, L.-J., Chen, P. S., Chen, S.-H., Chu, C.-H., Huang, S.-Y., Tzeng, N.-S., et al. (2016) · Scientific Reports · doi:10.1038/srep27431 · Cited by 21 · see citing works

Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder?

Wu, X., Chen, Z., Liao, Y., Yang, Z., Liang, X., Guan, N., & Gan, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1063479 · Cited by 23 · see citing works

Immune abnormalities across psychiatric disorders: clinical relevance

Mondelli, V., Dazzan, P., & Pariante, C. M. (2015) · BJPsych Advances · doi:10.1192/apt.bp.114.012872 · Cited by 17 · see citing works

The lipid paradox in neuroprogressive disorders: Causes and consequences

Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17 · see citing works

Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder

Sanchez-Autet, M., Arranz, B., Sierra, P., Safont, G., Garcia-Blanco, A., de la Fuente, L., Garriga, M., Marín, L., & García-Portilla, M. P. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013089 · Cited by 15 · see citing works

The adverse effects of smoking on health outcomes in bipolar disorder: a review and synthesis of biological mechanisms

Slyepchenko, A., Brunoni, A. R., McIntyre, R. S., Quevedo, J., & Carvalho, A. F. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144601 · Cited by 14 · see citing works

Evaluation of systemic immune inflammation index and neutrophil-to-lymphocyte ratio in schizophrenia, bipolar disorder and depression

(2024) · doi:10.4149/bll_2024_73 · Cited by 12 · see citing works

Causal relationship between bipolar disorder and inflammatory bowel disease: A bidirectional two-sample mendelian randomization study

Wang, Z., Wang, X., Zhao, X., Hu, Z., Sun, D., Wu, D., & Xing, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.970933 · Cited by 10 · see citing works

Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses

Koopman, L., van der Heijden, G. J. M. G., Hoes, A. W., Grobbee, D. E., & Rovers, M. M. (2008) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462308080471 · Cited by 48 · see citing works

Meta-analysis of the changes of peripheral blood regulatory T cell to CD4+ T cell ratio in patients with systemic sclerosis

Deng, C., Li, W., Chen, S., et al. (2017) · Scientific Reports · doi:10.1038/srep43532 · Cited by 5 · see citing works

Success rate of sialendoscopy. A systematic review and meta‐analysis

Beumer, L. J., Vissink, A., Gareb, B., et al. (2023) · Oral Diseases · doi:10.1111/odi.14662 · Cited by 17 · see citing works

Endotoxin-lnduced Release of Interleukin 6 and Interleukin 1β in Human Blood Is Independent of Tumor Necrosis Factor Alpha

Vasilescu, C., Berger, D., n, K. B. O., et al. (2008) · European Surgical Research · doi:10.1159/000129440 · Cited by 11 · see citing works

The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.

Shan, D., Shen, K., Zhu, J., et al. (2015) · PubMed · Cited by 4 · see citing works